Leo Pharma Sues Perrigo Israel Over Generic Taclonex

By Dan Rivoli · February 16, 2011, 5:18 PM EST

Leo Pharma A/S has sued generic-drug maker Perrigo Israel Pharmaceuticals Ltd. to block it from selling its own version of the Danish company's Taclonex ointment, used to treat the skin disease...

To view the full article, register now.

Documents

Case Information

Case Title

Leo Pharma A/S v. Perrigo Isrel Pharma Ltd.

Case Number

1:11-cv-00963

Court

New York Southern

Nature of Suit

Patent

Date Filed

February 14, 2011